The artificial pancreas: Is it important to understand how the β cell controls blood glucose?

Journal of Diabetes Science and Technology

Volumn 7, Issue 5, 2013, Pages 1359-1369

  Steil, Garry M ^a   Grodsky, Gerold M ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Artificial pancreas; First phase insulin; Insulin secretion; Physiologic insulin delivery; cell

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ARTIFICIAL PANCREAS; COMPARATIVE STUDY; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN RELEASE; INSULIN RESPONSE; PANCREAS; PANCREAS ISLET BETA CELL; REVIEW; ALGORITHM; BIOLOGICAL MODEL; PHYSIOLOGY;

ALGORITHMS; BLOOD GLUCOSE; HUMANS; INSULIN-SECRETING CELLS; MODELS, BIOLOGICAL; PANCREAS, ARTIFICIAL;

EID: 84900564428     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681300700528     Document Type: Review

References (74)

1. Curry DL, Bennett LL, Grodsky GM. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology. 1968;83(3):572-84.
2. Grodsky GM. A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling. J Clin Invest. 1972;51(8):2047-59.
3. O'Connor MD, Landahl H, Grodsky GM. Comparison of storage- and signal-limited models of pancreatic insulin secretion. Am J Physiol. 1980;238(5):R378-89.
4. Grill V. Time and dose dependencies for priming efect of glucose on insulin secretion. Am J Physiol. 1981;240(1):E24-31.
5. Grodsky GM, Landahl H, Curry DL, Bennett LL. In vitro studies suggesting a two-compartmental model for insulin secretion. In: Falkmer S, Hellman B, Taljedal IB, eds. The structure and metabolism of the pancreatic islets. Oxford: Pergamon Press; 1970, 409-20.
6. Cerasi E, Fick G, Rudemo M. A mathematical model for the glucose induced insulin release in man. Eur J Clin Invest. 1974;4(4):267-78.
7. Porte D Jr, Pupo AA. Insulin responses to glucose: evidence for a two pool system in man. J Clin Invest. 1969;48(12):2309-19.
8. Daniel S, Noda M, Straub SG, Sharp GW. Identification of the docked granule pool responsible for the first phase of glucose-stimulated insulin secretion. Diabetes. 1999;48(9):1686-90. (Pubitemid 29415184)
9. Olofsson CS, Göpel SO, Barg S, Galvanovskis J, Ma X, Salehi A, Rorsman P, Eliasson L. Fast insulin secretion reflects exocytosis of docked granules in mouse pancreatic B-cells. Pflugers Arch. 2002;444(1-2):43-51. (Pubitemid 34499244)
10. Ohara-Imaizumi M, Nishiwaki C, Kikuta T, Kumakura K, Nakamichi Y, Nagamatsu S. Site of docking and fusion of insulin secretory granules in live MIN6 beta cells analyzed by TAT-conjugated anti-syntaxin 1 antibody and total internal reflection fluorescence microscopy. J Biol Chem. 2004;279(9):8403-8. (Pubitemid 38294733)
11. Kikuta T, Ohara-Imaizumi M, Nakazaki M, Nishiwaki C, Nakamichi Y, Tei C, Aguilar-Bryan L, Bryan J, Nagamatsu S. Docking and fusion of insulin secretory granules in SUR1 knock out mouse beta-cells observed by total internal reflection fluorescence microscopy. FEBS Lett. 2005;579(7):1602-6. (Pubitemid 40341530)
12. Gold G, Landahl HD, Gishizky ML, Grodsky GM. Heterogeneity and compartmental properties of insulin storage and secretion in rat islets. J Clin Invest. 1982;69(3):554-63. (Pubitemid 12184951)
13. Gold G, Gishizky ML, Grodsky GM. Evidence that glucose "marks" beta cells resulting in preferential release of newly synthesized insulin. Science. 1982;218(4567):56-8. (Pubitemid 12024618)
14. Pedersen MG, Corradin A, Tofolo GM, Cobelli C. A subcellular model of glucose-stimulated pancreatic insulin secretion. Philos Trans A Math Phys Eng Sci. 2008;366(1880):3525-43.
15. Herrero P, Georgiou P, Oliver N, Johnston DG, Toumazou C. A bio-inspired glucose controller based on pancreatic β cell physiology. J Diabetes Sci Technol. 2012;6(3):606-16.
16. O'Connor MD, Landahl HD, Grodsky GM. Role of rate of change of glucose concentration as a signal for insulin release. Endocrinology. 1977;101(1):85-8. (Pubitemid 8141308)
17. Stamper IJ, Wang X. Mathematical modeling of insulin secretion and the role of glucose-dependent mobilization, docking, priming and fusion of insulin granules. J Theor Biol. 2013;318:210-25.
18. Steil GM, Panteleon AE, Rebrin K. Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev. 2004;56(2):125-44. (Pubitemid 38114927)
19. Ogata K. Modern control engineering. 4th ed. Upper Saddle River: Prentice Hall; 2002.
20. Rebrin K, Fischer U, von Woedtke T, Abel P, Brunstein E. Automated feedback control of subcutaneous glucose concentration in diabetic dogs. Diabetologia. 1989;32(8):573-6. (Pubitemid 19215438)
21. Steil GM, Rebrin K, Janowski R, Darwin C, Saad MF. Modeling beta-cell insulin secretion - implications for closed-loop glucose homeostasis. Diabetes Technol Ther. 2003;5(6):953-64. (Pubitemid 38009933)
22. Holterhus PM, Bokelmann J, Riepe F, Heidtmann B, Wagner V, Rami-Merhar B, Kapellen T, Raile K, Quester W, Holl RW; German/Austrian DPV-Initiative and the German Pediatric CSII Working Group. Predicting the optimal basal insulin infusion pattern in children and adolescents on insulin pumps. Diabetes Care. 2013;36(6):1507-11.
23. Valla V. Continuous subcutaneous insulin infusion (CSII) pumps. Adv Exp Med Biol. 2012;771:414-9.
24. Karam JH, Grodsky GM, Forsham PH. Excessive insulin response to glucose in obese subjects as measured by immunochemical assay. Diabetes. 1963;12:197-204.
25. Breda E, Cavaghan MK, Tofolo G, Polonsky KS, Cobelli C. Oral glucose tolerance test minimal model indexes of beta-cell function and insulin sensitivity. Diabetes. 2001;50(1):150-8. (Pubitemid 32047994)
26. Steil GM, Hwu CM, Janowski R, Hariri F, Jinagouda S, Darwin C, Tadros S, Rebrin K, Saad MF. Evaluation of insulin sensitivity and beta-cell function indexes obtained from minimal model analysis of a meal tolerance test. Diabetes. 2004;53(5):1201-7. (Pubitemid 38569004)
27. Åström KJ and Hägglund T. Auto-tuners for PID Controllers -The Impact of Control Technology, T. Samad and A.M. Annaswamy (eds.), IEEE Control Systems Society, 2011, available at www.ieeecss.org.
28. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981;68(6):1456-67. (Pubitemid 12194400)
29. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes. 2002;51 Suppl 1:S212-20. (Pubitemid 34761518)
30. King DS, Staten MA, Kohrt WM, Dalsky GP, Elahi D, Holloszy JO. Insulin secretory capacity in endurance-trained and untrained young men. Am J Physiol. 1990;259(2 Pt 1):E155-61. (Pubitemid 20255706)
31. Elahi D. In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance. Diabetes Care. 1996;19(3):278-86. (Pubitemid 26070357)
32. Elahi D, Nagulesparan M, Hershcopf RJ, Muller DC, Tobin JD, Blix PM, Rubenstein AH, Unger RH, Andres R. Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med. 1982;306(20):1196-202. (Pubitemid 12158849)
33. Meneilly GS, Elahi D. Physiological importance of first-phase insulin release in elderly patients with diabetes. Diabetes Care. 1998;21(8):1326-9. (Pubitemid 28365692)
34. Steil GM, Rebrin K, Mittelman SD, Bergman RN. Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity. Diabetes. 1998;47(5):714-20. (Pubitemid 28201799)
35. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-23. (Pubitemid 9249478)
36. Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care. 1999;22(9):1501-6. (Pubitemid 29418246)
37. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55(12):3344-50. (Pubitemid 44923591)
38. Clemens AH, Chang PH, Myers RW. The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS). Horm Metab Res. 1977;Suppl 7:23-33.
39. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31(5):934-9.
40. Steil GM, Palerm CC, Kurtz N, Voskanyan G, Roy A, Paz S, Kandeel FR. The efect of insulin feedback on closed loop glucose control. J Clin Endocrinol Metab. 2011;96(5):1402-8.
41. Tef KL. How neural mediation of anticipatory and compensatory insulin release helps us tolerate food. Physiol Behav. 2011;103(1):44-50.
42. Steil GM, Rebrin K, Hariri F, Jinagonda S, Tadros S, Darwin C, Saad MF. Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia. 2005;48(9):1833-40. (Pubitemid 41317838)
43. Eaton RP, Allen RC, Schade DS, Erickson KM, Standefer J. Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. J Clin Endocrinol Metab. Sep 1980;51(3):520-8. (Pubitemid 10022835)
44. Van Cauter E, Mestrez F, Sturis J, Polonsky KS. Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes. 1992;41(3):368-77.
45. Ruiz JL, Sherr JL, Cengiz E, Carria L, Roy A, Voskanyan G, Tamborlane WV, Weinzimer SA. Effect of insulin feedback on closed-loop glucose control: a crossover study. J Diabetes Sci Technol. 2012;6(5):1123-30.
46. Dauber A, Corcia L, Safer J, Agus MS, Einis S, Steil GM. Closed-loop insulin therapy improves glycemic control in children aged <7 years: a randomized controlled trial. Diabetes Care. 2013;36(2):222-7.
47. Kanderian S, Steil G. Apparatus and method for controling insulin infusion with state varible feedback. U.S. Patent Application 2007/0173761. July 26, 2007.
48. Loutseiko M, Voskanyan G, Keenan DB, Steil GM. Closed-loop insulin delivery utilizing pole placement to compensate for delays in subcutaneous insulin delivery. J Diabetes Sci Technol. 2011;5(6):1342-51.
49. Steil GM, Ader M, Moore DM, Rebrin K, Bergman RN. Transendothelial insulin transport is not saturable in vivo. No evidence for a receptor-mediated process. J Clin Invest. 1996;97(6):1497-503.
50. Franklin GF, Powell JD, Workman ML. Digital control of dynamic systems. Reading: Addison-Wesley; 1980, 220-4.
51. Grodsky GM, Fanska R, Schmid FG. Evaluation of the role of exogenous insulin on phasic insulin secretion. Diabetes. 1973;22(4):256-63.
52. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF. Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol. 1999;276(6 Pt 1):E1055-66. (Pubitemid 29323421)
53. Rebrin K, Steil GM, Mittelman SD, Bergman RN. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest. 1996;98(3):741-9. (Pubitemid 26349179)
54. Ly TT, Nicholas JA, Retterath A, Davis EA, Jones TW. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy. Diabetes Care. 2012;35(7):1462-5.
55. Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonof DC, Shin J, Welsh JB, Kaufman FR. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther. 2012;14(3):205-9.
56. Wolpert HA, Atakov-Castillo A, Smith SA, Steil GM. Dietary fat acutely increases glucose concentrations and insulin requirements in patients with type 1 diabetes: implications for carbohydrate-based bolus dose calculation and intensive diabetes management. Diabetes Care. 2013;36(4):810-6.
57. Poulin RA, Steil GM, Moore DM, Ader M, Bergman RN. Dynamics of glucose production and uptake are more closely related to insulin in hindlimb lymph than in thoracic duct lymph. Diabetes. 1994;43(2):180-90. (Pubitemid 24033670)
58. Rebrin K, Steil GM, Getty L, Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes. 1995;44(9):1038-45.
59. Mittelman SD, Fu YY, Rebrin K, Steil G, Bergman RN. Indirect efect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest. 1997;100(12):3121-30. (Pubitemid 28022850)
60. Bergman RN. New concepts in extracellular signaling for insulin action: the single gateway hypothesis. Recent Prog Horm Res. 1997;52:359-87.
61. Renard E, Place J, Cantwell M, Chevassus H, Palerm CC. Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas. Diabetes Care. 2010;33(1):121-7.
62. Wintergerst KA, Deiss D, Buckingham B, Cantwell M, Kache S, Agarwal S, Wilson DM, Steil G. Glucose control in pediatric intensive care unit patients using an insulin-glucose algorithm. Diabetes Technol Ther. 2007;9(3):211-22. (Pubitemid 46959786)
63. Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, Alexander JL, Scoppettuolo LA, Pigula FA, Charpie JR, Ohye RG, Gaies MG; SPECS Study Investigators. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012;367(13):1208-19.
64. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER. A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010;2(27):27ra27.
65. Russell SJ, El-Khatib FH, Nathan DM, Magyar KL, Jiang J, Damiano ER. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care. 2012;35(11):2148-55.
66. Elleri D, Allen JM, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Acerini CL, Dunger DB, Hovorka R. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes. 2012;13(6):449-53.
67. Elleri D, Allen JM, Kumareswaran K, Leelarathna L, Nodale M, Caldwell K, Cheng P, Kollman C, Haidar A, Murphy HR, Wilinska ME, Acerini CL, Dunger DB, Hovorka R. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care. 2013;36(4):838-44.
68. Elleri D, Dunger DB, Hovorka R. Closed-loop insulin delivery for treatment of type 1 diabetes. BMC Med. 2011;9:120.
69. Dassau E, Zisser H, Harvey RA, Percival MW, Grosman B, Bevier W, Atlas E, Miller S, Nimri R, Jovanovic L, Doyle FJ 3rd. Clinical evaluation of a personalized artificial pancreas. Diabetes Care. 2013;36(4):801-9.
70. Cobelli C, Renard E, Kovatchev BP, Keith-Hynes P, Ben Brahim N, Place J, Del Favero S, Breton M, Farret A, Bruttomesso D, Dassau E, Zisser H, Doyle FJ 3rd, Patek SD, Avogaro A. Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care. 2012;35(9):e65-7.
71. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technol. 2009;3(5):1031-8.
72. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Tofanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B; International Artificial Pancreas Study Group. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes. 2012;61(9):2230-7.
73. Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T, Avbelj M, Miller S, Muller I, Phillip M, Battelino T. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Pediatr Diabetes. 2013;14(3):159-67.
74. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013 Feb 28;368(9):824-33.